{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T17:48:05Z","timestamp":1759340885979},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,11,28]],"date-time":"2012-11-28T00:00:00Z","timestamp":1354060800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Surg Int"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1007\/s00383-012-3192-5","type":"journal-article","created":{"date-parts":[[2012,11,29]],"date-time":"2012-11-29T15:23:29Z","timestamp":1354202609000},"page":"121-127","source":"Crossref","is-referenced-by-count":7,"title":["Effect of duplex drugs linking 2\u2032-deoxy-5-fluorouridine (5-FdU) with 3\u2032-C-ethynylcytidine (ECyd) on hepatoblastoma cell lines"],"prefix":"10.1007","volume":"29","author":[{"given":"Carmen","family":"Eicher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Dewerth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Verena","family":"Ellerkamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joerg","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Schott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sorin","family":"Armeanu-Ebinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,11,28]]},"reference":[{"issue":"3","key":"3192_CR1","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/1097-0142(1967)20:3<396::AID-CNCR2820200308>3.0.CO;2-O","volume":"20","author":"KG Ishak","year":"1967","unstructured":"Ishak KG, Glunz PR (1967) Hepatoblastoma and hepatocarcinoma in infancy and childhood. Report of 47 cases. Cancer 20(3):396\u2013422","journal-title":"Cancer"},{"issue":"17","key":"3192_CR2","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1056\/NEJMoa0810613","volume":"361","author":"G Perilongo","year":"2009","unstructured":"Perilongo G, Maibach R, Shafford E et al (2009) Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma. N Engl J Med 361(17):1662\u20131670","journal-title":"N Engl J Med"},{"issue":"15","key":"3192_CR3","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1200\/JCO.2009.22.4857","volume":"28","author":"J Zsiros","year":"2010","unstructured":"Zsiros J, Maibach R, Shafford E et al (2010) Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: final results of the SIOPEL-3HR study. J Clin Oncol 28(15):2584\u20132590","journal-title":"J Clin Oncol"},{"issue":"6","key":"3192_CR4","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1200\/JCO.2005.07.145","volume":"23","author":"DC Aronson","year":"2005","unstructured":"Aronson DC, Schnater JM, Staalman CR et al (2005) Predictive value of the pretreatment extent of disease system in hepatoblastoma: results from the International Society of Pediatric Oncology Liver Tumor Study Group SIOPEL-1 study. J Clin Oncol 23(6):1245\u20131252","journal-title":"J Clin Oncol"},{"issue":"3","key":"3192_CR5","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00247-005-0064-3","volume":"36","author":"DJ Roebuck","year":"2006","unstructured":"Roebuck DJ, Perilongo G (2006) Hepatoblastoma: an oncological review. Pediatr Radiol 36(3):183\u2013186","journal-title":"Pediatr Radiol"},{"issue":"1","key":"3192_CR6","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/1097-0045(20000915)45:1<8::AID-PROS2>3.0.CO;2-L","volume":"45","author":"RM Cattaneo-Pangrazzi","year":"2000","unstructured":"Cattaneo-Pangrazzi RM, Schott H, Schwendener RA (2000) The novel heterodinucleoside dimer 5-FdU-NOAC is a potent cytotoxic drug and a p53-independent inducer of apoptosis in the androgen-independent human prostate cancer cell lines PC-3 and DU-145. Prostate 45(1):8\u201318","journal-title":"Prostate"},{"issue":"19","key":"3192_CR7","doi-asserted-by":"crossref","first-page":"6824","DOI":"10.1016\/j.bmc.2009.08.033","volume":"17","author":"H Schott","year":"2009","unstructured":"Schott H, Schott S, Schwendener RA (2009) Synthesis and in vitro activities of new anticancer duplex drugs linking 2\u2032-deoxy-5-fluorouridine (5-FdU) with 3\u2032-C-ethynylcytidine (ECyd) via a phosphodiester bonding. Bioorg Med Chem 17(19):6824\u20136831","journal-title":"Bioorg Med Chem"},{"issue":"16","key":"3192_CR8","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1021\/jm980539w","volume":"42","author":"JP Krise","year":"1999","unstructured":"Krise JP, Zygmunt J, Georg GI, Stella VJ (1999) Novel prodrug approach for tertiary amines: synthesis and preliminary evaluation of N-phosphonooxymethyl prodrugs. J Med Chem 42(16):3094\u20133100","journal-title":"J Med Chem"},{"key":"3192_CR9","first-page":"21","volume":"19","author":"W Plunkett","year":"2001","unstructured":"Plunkett W, Gandhi V (2001) Purine and pyrimidine nucleoside analogs. Cancer Chemother Biol Response Modif 19:21\u201345","journal-title":"Cancer Chemother Biol Response Modif"},{"issue":"5","key":"3192_CR10","first-page":"1373","volume":"34","author":"H Kazuno","year":"2009","unstructured":"Kazuno H, Fujioka A, Fukushima M et al (2009) 1-(3-C-Ethynyl-beta-D-ribo-pentofuranosyl)cytosine (ECyd, TAS-106), a novel potent inhibitor of RNA polymerase, potentiates the cytotoxicity of CDDP in human cancer cells both in vitro and in vivo. Int J Oncol 34(5):1373\u20131380","journal-title":"Int J Oncol"},{"issue":"5","key":"3192_CR11","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s00280-008-0810-y","volume":"63","author":"T Naito","year":"2009","unstructured":"Naito T, Yokogawa T, Takatori S et al (2009) Role of RNase L in apoptosis induced by 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine. Cancer Chemother Pharmacol 63(5):837\u2013850","journal-title":"Cancer Chemother Pharmacol"},{"issue":"3","key":"3192_CR12","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1007\/s10637-009-9355-0","volume":"29","author":"S Schott","year":"2011","unstructured":"Schott S, Wallwiener M, Kootz B et al (2011) ATP chemosensitivity testing of new antitumor duplex drugs linking 3`-C-ethynylycytidine (ECyd) and 2-deoxy-5-fluorouridine (5-FdU) in comparison to standard cytostatica and combinations thereof. Invest New Drugs 29(3):506\u2013513","journal-title":"Invest New Drugs"},{"issue":"6","key":"3192_CR13","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1007\/s10637-010-9483-6","volume":"29","author":"J Weinreich","year":"2011","unstructured":"Weinreich J, Schott S, Konigsrainer I et al (2011) Cytostatic activity of the duplex drug linking 2\u2032-deoxy-5-fluorouridine (5FdU) with 3\u2032-C-ethynylcytidine (ECyd) against gastric adenocarcinoma cell lines. Invest New Drugs 29(6):1294\u20131302","journal-title":"Invest New Drugs"},{"issue":"12","key":"3192_CR14","first-page":"4891","volume":"30","author":"L Novotny","year":"2010","unstructured":"Novotny L, Rauko P, Schott H (2010) Cytotoxicity and antileukaemic activity of new duplexes linking 3-C-ethynylcytidine and 5-fluorodeoxyuridine. Anticancer Res 30(12):4891\u20134898","journal-title":"Anticancer Res"},{"issue":"9","key":"3192_CR15","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1002\/ijc.27476","volume":"131","author":"S Schott","year":"2012","unstructured":"Schott S, Niessner H, Sinnberg T et al (2012) Cytotoxicity of new duplex drugs linking 3\u2032-C-ethynylcytidine and 5-fluor-2\u2032-deoxyuridine against human melanoma cells. Int J Cancer 131(9):2165\u20132174","journal-title":"Int J Cancer"},{"issue":"1","key":"3192_CR16","first-page":"1","volume":"67","author":"I Doi","year":"1976","unstructured":"Doi I (1976) Establishment of a cell line and its clonal sublines from a patient with hepatoblastoma. Gann 67(1):1\u201310","journal-title":"Gann"},{"issue":"4","key":"3192_CR17","first-page":"809","volume":"74","author":"T Pietsch","year":"1996","unstructured":"Pietsch T, Fonatsch C, Albrecht S et al (1996) Characterization of the continuous cell line HepT1 derived from a human hepatoblastoma. Lab Invest 74(4):809\u2013818","journal-title":"Lab Invest"},{"key":"3192_CR18","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1186\/1471-2407-11-362","volume":"11","author":"J Lieber","year":"2011","unstructured":"Lieber J, Eicher C, Wenz J et al (2011) The BH3 mimetic ABT-737 increases treatment efficiency of paclitaxel against hepatoblastoma. BMC Cancer 11:362","journal-title":"BMC Cancer"},{"issue":"2","key":"3192_CR19","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00383-011-2988-z","volume":"28","author":"J Lieber","year":"2012","unstructured":"Lieber J, Ellerkamp V, Wenz J et al (2012) Apoptosis sensitizers enhance cytotoxicity in hepatoblastoma cells. Pediatr Surg Int 28(2):149\u2013159","journal-title":"Pediatr Surg Int"},{"issue":"2","key":"3192_CR20","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s10637-009-9353-2","volume":"29","author":"IV Bijnsdorp","year":"2011","unstructured":"Bijnsdorp IV, Schwendener RA, Schott H et al (2011) Cellular pharmacology of multi- and duplex drugs consisting of ethynylcytidine and 5-fluoro-2\u2032-deoxyuridine. Invest New Drugs 29(2):248\u2013257","journal-title":"Invest New Drugs"},{"issue":"5","key":"3192_CR21","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.ejmech.2004.12.006","volume":"40","author":"PS Ludwig","year":"2005","unstructured":"Ludwig PS, Schwendener RA, Schott H (2005) Synthesis and anticancer activities of amphiphilic 5-fluoro-2\u2032-deoxyuridylic acid prodrugs. Eur J Med Chem 40(5):494\u2013504","journal-title":"Eur J Med Chem"},{"issue":"5","key":"3192_CR22","doi-asserted-by":"crossref","first-page":"e38223","DOI":"10.1371\/journal.pone.0038223","volume":"7","author":"S Armeanu-Ebinger","year":"2012","unstructured":"Armeanu-Ebinger S, Wenz J, Seitz G et al (2012) Characterisation of the Cell Line HC-AFW1 derived from a pediatric hepatocellular carcinoma. PLoS One 7(5):e38223","journal-title":"PLoS One"},{"issue":"1","key":"3192_CR23","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/cncr.10632","volume":"95","author":"J Fuchs","year":"2002","unstructured":"Fuchs J, Rydzynski J, von Schweinitz D et al (2002) Pretreatment prognostic factors and treatment results in children with hepatoblastoma: a report from the German Cooperative Pediatric Liver Tumor Study HB 94. Cancer 95(1):172\u2013182","journal-title":"Cancer"},{"issue":"6","key":"3192_CR24","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/0022-3468(95)90762-9","volume":"30","author":"SD Schweinitz von","year":"1995","unstructured":"von Schweinitz SD, Hecker H, Harms D et al (1995) Complete resection before development of drug resistance is essential for survival from advanced hepatoblastoma\u2014a report from the German Cooperative Pediatric Liver Tumor Study HB-89. J Pediatr Surg 30(6):845\u2013852","journal-title":"J Pediatr Surg"},{"issue":"14","key":"3192_CR25","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1200\/JCO.2000.18.14.2665","volume":"18","author":"JA Ortega","year":"2000","unstructured":"Ortega JA, Douglass EC, Feusner JH et al (2000) Randomized comparison of cisplatin\/vincristine\/fluorouracil and cisplatin\/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: a report from the Children\u2019s Cancer Group and the Pediatric Oncology Group. J Clin Oncol 18(14):2665\u20132675","journal-title":"J Clin Oncol"},{"key":"3192_CR26","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S1470-2045(00)00018-8","volume":"1","author":"G Perilongo","year":"2000","unstructured":"Perilongo G, Shafford E, Plaschkes J (2000) SIOPEL trials using preoperative chemotherapy in hepatoblastoma. Lancet Oncol 1:94\u2013100","journal-title":"Lancet Oncol"},{"issue":"6","key":"3192_CR27","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1053\/jpsu.2002.32886","volume":"37","author":"F Sasaki","year":"2002","unstructured":"Sasaki F, Matsunaga T, Iwafuchi M et al (2002) Outcome of hepatoblastoma treated with the JPLT-1 (Japanese Study Group for Pediatric Liver Tumor) Protocol-1: a report from the Japanese Study Group for Pediatric Liver Tumor. J Pediatr Surg 37(6):851\u2013856","journal-title":"J Pediatr Surg"},{"issue":"2","key":"3192_CR28","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/pbc.21956","volume":"53","author":"SW Warmann","year":"2009","unstructured":"Warmann SW, Armeanu S, Heigoldt H et al (2009) Adenovirus-mediated cytosine deaminase\/5-fluorocytosine suicide gene therapy of human hepatoblastoma in vitro. Pediatr Blood Cancer 53(2):145\u2013151","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"3192_CR29","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.ccr.2008.11.002","volume":"14","author":"S Cairo","year":"2008","unstructured":"Cairo S, Armengol C, de Reynies A et al (2008) Hepatic stem-like phenotype and interplay of Wnt\/beta-catenin and Myc signaling in aggressive childhood liver cancer. Cancer Cell 14(6):471\u2013484","journal-title":"Cancer Cell"},{"issue":"6","key":"3192_CR30","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1002\/pbc.22740","volume":"55","author":"J Lieber","year":"2010","unstructured":"Lieber J, Kirchner B, Eicher C et al (2010) Inhibition of Bcl-2 and Bcl-X enhances chemotherapy sensitivity in hepatoblastoma cells. Pediatr Blood Cancer 55(6):1089\u20131095","journal-title":"Pediatr Blood Cancer"}],"container-title":["Pediatric Surgery International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00383-012-3192-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00383-012-3192-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00383-012-3192-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T16:00:26Z","timestamp":1559059226000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00383-012-3192-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,28]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["3192"],"URL":"https:\/\/doi.org\/10.1007\/s00383-012-3192-5","relation":{},"ISSN":["0179-0358","1437-9813"],"issn-type":[{"value":"0179-0358","type":"print"},{"value":"1437-9813","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,28]]}}}